enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN)


$6.0500
+0.0900 ( -0.82% ) 24.4K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$6.0500

Previous close


$5.9600

Volume


24.4K

Market cap


$317.59M

Day range


$6.0550 - $6.5500

52 week range


$4.4200 - $18.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Dec 20, 2024
8-k 8K-related 13 Dec 19, 2024
10-k Annual reports 118 Dec 19, 2024
4 Insider transactions 1 Nov 01, 2024
8-k 8K-related 46 Oct 25, 2024
4 Insider transactions 1 Oct 22, 2024
3 Insider transactions 2 Oct 22, 2024
4 Insider transactions 1 Oct 22, 2024
8-k 8K-related 14 Oct 21, 2024
4 Insider transactions 1 Oct 18, 2024

Latest News